Haleon plc — Form 6-K Summary
Business Context and Reporting Period
Haleon plc is a global consumer-health company operating across oral health, pain relief, respiratory health, digestive health, and vitamins, minerals and supplements. This Form 6-K, filed on 15 March 2024, reports the publication of the company’s Annual Report and Form 20-F for the year ended 31 December 2023.
Financial and Operating Metrics
The filing announces the availability of the annual report but does not include financial statements or specific values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. The complete audited financial statements are contained in the Annual Report.
Material Changes Versus Prior Period
The filing text does not provide a clear comparison with the prior comparable period or identify specific changes in financial performance.
Outlook, Risks, and Other Matters
- The Annual Report and Form 20-F were submitted to the UK National Storage Mechanism and filed with the U.S. Securities and Exchange Commission.
- The report is available on Haleon’s investor-relations website and may be requested in hard copy from the company.
- Haleon’s Annual General Meeting is scheduled for 8 May 2024; the notice of meeting was to be published and distributed later.
- The filing does not provide new guidance, management forecasts, risk updates, contingencies, or unusual items beyond the publication announcement.
Key Facts for Investors to Verify
- Review the complete 2023 Annual Report and audited financial statements for revenue, profitability, cash flow, leverage, liquidity, and segment performance.
- Check the report’s discussion of material risks, litigation, contingencies, impairment, restructuring, and other unusual items.
- Confirm any 2024 guidance, capital-allocation plans, dividend information, and management outlook in the Annual Report and subsequent company disclosures.
- Monitor the 8 May 2024 Annual General Meeting and the publication of its notice and resolutions.